Eagle Pharmaceuticals
EGRX
$4.57
Share price
3.63%
Change (1 day)
-84.33%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) - Net assets
Net assets on the balance sheet as of June 2023 : $0.25 B
According to Eagle Pharmaceuticals
's latest financial reports the company has $0.25 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Eagle Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.23 B | 32.36% |
| 2021-12-31 | $0.17 B | -5.14% |
| 2020-12-31 | $0.18 B | 3.82% |
| 2019-12-31 | $0.17 B | 11.45% |
| 2018-12-31 | $0.16 B | -10.26% |
| 2017-12-31 | $0.17 B | 18.46% |
| 2016-12-31 | $0.15 B | 67.39% |
| 2015-12-31 | $90.34 M | |
| 2014-09-30 | $33.09 M | 1511.3% |
| 2013-09-30 | $2.05 M | -116.98% |
| 2012-09-30 | $-12.1 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 27,681.30% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 15,673.69% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $12.89 B | 5,017.20% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 2,372.62% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $16.54 B | 6,465.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.71 B | 6,532.99% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 3,124.09% | 🇮🇱 Israel |